Drug intelligence / Profile preview

Immiflex

Development stage
Unknown
Lead developer
Immitec
Modality
Small Molecules
Administration
Oral
01

Overview

Immiflex is a dietary supplement marketed for immune system support, primarily distributed in certain regions by Bolar Pharmaceuticals. It contains a combination of Wellmune WGP, a proprietary beta-1,3/1,6-glucan derived from the cell walls of a highly purified strain of baker's yeast (*Saccharomyces cerevisiae*), and Vitamin D3 (cholecalciferol). The product is designed to prime innate immune cells, such as neutrophils and macrophages, to respond more effectively to pathogens without overstimulating the immune system. The beta-glucan component acts as an agonist at the Dectin-1 receptor, while Vitamin D3 supports overall immune function and calcium homeostasis. It is typically used as a consumer health product rather than a prescription pharmaceutical.

Brand names
Immiflex
Other names
beta-glucan + vitamin D3
02

Targets

VDR (Vitamin D receptor)TLR4 (Toll-like receptor 4)TLR5CLEC7A (Dectin-1)TLR2 (Toll-like Receptor 2)

Beyond the preview

Go deeper on Immiflex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immiflex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call